Drug: |
||||
---|---|---|---|---|
Trial Name: |
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma |
|||
NCT#: |
||||
Conditions: |
Sarcoma |
|||
Status: |
Does not allow GIST |
|||
Phase: |
2 |
Start Date 07/01/2008 |
Age of Trial (yrs) 16.4 |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
IGF1R inhibitor |
|||
Strategy: |
Block related tumor signal paths |
|||
Trial Type: |
GIST not specified. GIST patient enrollment unknown. |
|||
Other Protocol IDs: |
SARC011
NO21157 |
|||
Sponsor: |
Hoffman-La Roche,
SARC |
|||
Patient Contact: |
Contact: Please reference Study ID Number: NO21157 973-235-5000
Contact: Please reference Study ID Number: SARC011 734-930 7600 (FOR US ONLY)
|
|||
Contact email: |
||||
Contact Phone: |
734-930 7600 |
|||
Randomized: |
||||
IV or Oral: |
Intravenous |
|||
Trial Notes: |
NOTE: Per SARC, this trial does not allow GIST patients. This trial specifies several sarcomas but not specifically GIST. As of 5/18/09 all previously opened sites are active but not recruiting except for Paris France. Trials of IGF1R inhibitors such as R1507, would be most appropriate for patients with wild-type GIST and/or pediatric GIST. |
Trial Links |
Trial Results |
Drug Information |
Genmab description of R1507 |
10/23/2007 - Roche Announces Positive Results in IGF-1R (R1507) Study and Plans for Future SARC Studies |
Roche halts development of R1507 |
Name |
Address |
City |
State |
Zip |
Country |
450 Brookline Ave |
Boston |
MA |
02215-5450 |
USA |
|
100 Blossom St |
Charlestown |
MA |
02114 |
USA |
|
Omaha |
NB |
68114 |
USA |
||
3181 S.W. Sam Jackson Park Rd. |
Portland |
OR |
97239 |
USA |
|
2000 Circle of Hope |
Salt Lake City |
UT |
84103 |
USA |
|
10 St Andrews Place |
East Melbourne |
Victoria |
3002 |
Australia |
|
Villejuif |
Val de Narne |
94805 |
France |
||
Lille |
Nord |
59020 |
France |
||
Munster |
68167 |
Germany |
|||
Mannheim |
68135 |
Germany |
|||
Lund |
SE-221 85 |
Sweden |
|||
550 Wilmslow Rd |
Manchester |
Lancashire |
M20 4BX |
UK |
|
Paris |
75248 |
France |